Compared to those in the HT-29 cells treated with HF serum, there were significant decreases in PCNA expression and proliferation in the miR-221-3p- and miR-222-3p-inhibiting groups (Figures 8H-J). The gene discussed is PCNA; the disease is hydrops fetalis.